|
Chromic P-32 Still Available
GE Healthcare Life Sciences division announced that it is discontinuing production of short-lived radiochemicals, specifically those products labeled with P-32, P-33, S-35, and I-125. This does not affect the availablilty of Chromic Phosphate P-32 radiopharmaceutical used in nuclear medicine. |
|
Triad Adds New Pharmacies Triad Isotopes announced the acquisition of four radiopharmaceutical companies that operate four nuclear pharmacies in South Carolina and Texas and one cyclotron in South Carolina. (see press release) |
|
USP <797> Revisions  The US Pharmacopeia has announced the revisions to USP Chapter 797 regarding the compounding of sterile preparations. View the press release for further information. |
|
APhA Officers  The APhA-APPM Nuclear Section is looking for new officers to serve the profession. It is a great professional experience! In 2008 the section will be electing new Chair-Elect and New Practitioner positions. Deadline for applications is Dec. 14th. Click here for more information. |
Bristol Myers Squibb has announced a shortage of Mo-99 that will affect Tc-99m generator production into next week. The shortage is a result of required regulatory upgrades at the Nordion reactor in Canada that produces the Mo-99 for BMS.
Several nuclear pharmacies have recently been inspected by special agent with the Federal Aviation Administration. The pharmacies that returned expired sources to the manufacturer via Fed-X were sited for not having documented DOT training for air shipments. The online training available from 
Many pharmacists are looking for continuing education credits before the Dec. 31st deadline. Nuclear CE courses are available from the 